BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 31514949)

  • 1. Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease: A Mendelian Randomization Study.
    Emanuelsson F; Nordestgaard BG; Tybjærg-Hansen A; Benn M
    J Am Coll Cardiol; 2019 Sep; 74(11):1465-1476. PubMed ID: 31514949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Glucose Level on Micro- and Macrovascular Disease in the General Population: A Mendelian Randomization Study.
    Emanuelsson F; Marott S; Tybjærg-Hansen A; Nordestgaard BG; Benn M
    Diabetes Care; 2020 Apr; 43(4):894-902. PubMed ID: 32054721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating linear and nonlinear associations of LDL cholesterol with incident chronic kidney disease, atherosclerotic cardiovascular disease and all-cause mortality: A prospective and Mendelian randomization study.
    Wang Z; Xiao Y; Lu J; Zou C; Huang W; Zhang J; Liu S; Han L; Jiao F; Tian D; Jiang Y; Du X; Ma RCW; Jiang G
    Atherosclerosis; 2023 Dec; 387():117394. PubMed ID: 38029611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study.
    Lanktree MB; Thériault S; Walsh M; Paré G
    Am J Kidney Dis; 2018 Feb; 71(2):166-172. PubMed ID: 28754456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipid levels and risk of retinal vascular occlusion: A genetic study using Mendelian randomization.
    Zheng C; Lin Y; Jiang B; Zhu X; Lin Q; Luo W; Tang M; Xie L
    Front Endocrinol (Lausanne); 2022; 13():954453. PubMed ID: 36299452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causal effect between total cholesterol and HDL cholesterol as risk factors for chronic kidney disease: a mendelian randomization study.
    Miao L; Min Y; Qi B; Zhu CM; Chen JH; Deng GX; Wang Y; Li JF; Li RS
    BMC Nephrol; 2021 Jan; 22(1):35. PubMed ID: 33472594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDL-Cholesterol versus Glucose in Microvascular and Macrovascular Disease.
    Emanuelsson F; Benn M
    Clin Chem; 2021 Jan; 67(1):167-182. PubMed ID: 33221847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of blood lipid profile with incident chronic kidney disease: A Mendelian randomization study.
    Zhang YB; Sheng LT; Wei W; Guo H; Yang H; Min X; Guo K; Yang K; Zhang X; He M; Wu T; Pan A
    Atherosclerosis; 2020 May; 300():19-25. PubMed ID: 32276134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease.
    Toth PP; Dwyer JP; Cannon CP; Colhoun HM; Rader DJ; Upadhyay A; Louie MJ; Koren A; Letierce A; Mandel J; Banach M
    Kidney Int; 2018 Jun; 93(6):1397-1408. PubMed ID: 29526502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Mendelian Randomization Approach Using 3-HMG-Coenzyme-A Reductase Gene Variation to Evaluate the Association of Statin-Induced Low-Density Lipoprotein Cholesterol Lowering With Noncardiovascular Disease Phenotypes.
    Liu G; Shi M; Mosley JD; Weng C; Zhang Y; Lee MTM; Jarvik GP; Hakonarson H; Namjou-Khales B; Sleiman P; Luo Y; Mentch F; Denny JC; Linton MF; Wei WQ; Stein CM; Feng Q
    JAMA Netw Open; 2021 Jun; 4(6):e2112820. PubMed ID: 34097045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low LDL cholesterol,
    Benn M; Nordestgaard BG; Frikke-Schmidt R; Tybjærg-Hansen A
    BMJ; 2017 Apr; 357():j1648. PubMed ID: 28438747
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.
    ; Herrington WG; Emberson J; Mihaylova B; Blackwell L; Reith C; Solbu MD; Mark PB; Fellström B; Jardine AG; Wanner C; Holdaas H; Fulcher J; Haynes R; Landray MJ; Keech A; Simes J; Collins R; Baigent C
    Lancet Diabetes Endocrinol; 2016 Oct; 4(10):829-39. PubMed ID: 27477773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization Study.
    Almramhi MM; Finan C; Storm CS; Schmidt AF; Kia DA; Coneys R; Chopade S; Hingorani AD; Wood NW
    Neurology; 2023 Oct; 101(17):e1729-e1740. PubMed ID: 37657941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital.
    Sangsawang T; Sriwijitkamol A
    Vasc Health Risk Manag; 2015; 11():563-7. PubMed ID: 26604773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Blood Lipids on the Left Ventricle: A Mendelian Randomization Study.
    Aung N; Sanghvi MM; Piechnik SK; Neubauer S; Munroe PB; Petersen SE
    J Am Coll Cardiol; 2020 Nov; 76(21):2477-2488. PubMed ID: 33213727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Causal Effect of Systolic Blood Pressure Lowering on Vascular Outcomes in Diabetes: A Mendelian Randomization Study.
    Hou T; Li M; Lin H; Zhao Z; Lu J; Wang T; Xu Y; Wang W; Bi Y; Ning G; Xu M
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2616-2625. PubMed ID: 35703944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.
    Vallejo-Vaz AJ; Fayyad R; Boekholdt SM; Hovingh GK; Kastelein JJ; Melamed S; Barter P; Waters DD; Ray KK
    Circulation; 2018 Aug; 138(8):770-781. PubMed ID: 29618599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remnant Cholesterol, Not LDL Cholesterol, Explains Peripheral Artery Disease Risk Conferred by apoB: A Cohort Study.
    Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1144-1155. PubMed ID: 38511326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney Disease.
    Emanuelsson F; Nordestgaard BG; Benn M
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4491-4500. PubMed ID: 30085243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.